UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$495M |
| 2 |
Microsoft
MSFT
|
+$480M |
| 3 |
Global Payments
GPN
|
+$400M |
| 4 |
Mastercard
MA
|
+$274M |
| 5 |
Comcast
CMCSA
|
+$254M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSS
Total System Services, Inc.
TSS
|
+$225M |
| 2 |
WP
Worldpay, Inc.
WP
|
+$190M |
| 3 |
Apple
AAPL
|
+$167M |
| 4 |
RHT
Red Hat Inc
RHT
|
+$166M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Financials | 14.07% |
| 3 | Healthcare | 13.13% |
| 4 | Consumer Discretionary | 12.1% |
| 5 | Communication Services | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RARX
1026
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $7.44M | 0.01% |
314,457
-3,853
| -1% | -$114K |
|
|
VRE
1027
DELISTED
Veris Residential
VRE
| $7.41M | 0.01% |
342,204
+36,934
| +12% | +$821K |
|
1028
Ligand Pharmaceuticals
LGND
$6.36B
| $7.4M | 0.01% |
119,164
+608
| +0.5% | +$38.2K |
|
1029
Ciena
CIEN
$58.4B
| $7.38M | 0.01% |
188,121
+23,439
| +14% | +$983K |
|
1030
Algonquin Power & Utilities
AQN
$4.42B
| $7.36M | 0.01% |
537,019
+96,449
| +22% | +$1.25M |
|
|
TCF
1031
DELISTED
TCF Financial Corporation Common Stock
TCF
| $7.34M | ﹤0.01% |
192,842
+123,494
| +178% | +$4.91M |
|
1032
Vanguard High Dividend Yield ETF
VYM
$82.8B
| $7.33M | ﹤0.01% |
82,600
-3,414
| -4% | -$299K |
|
|
NSA
1033
DELISTED
National Storage Affiliates Trust
NSA
| $7.31M | ﹤0.01% |
219,177
+34,160
| +18% | +$1.08M |
|
1034
Thor Industries
THO
$4.14B
| $7.31M | ﹤0.01% |
129,018
+6,548
| +5% | +$344K |
|
1035
Landstar System
LSTR
$6.21B
| $7.29M | ﹤0.01% |
64,719
+1,060
| +2% | +$117K |
|
1036
Interactive Brokers
IBKR
$39.8B
| $7.28M | ﹤0.01% |
541,264
-79,948
| -13% | -$994K |
|
1037
Vanguard FTSE Emerging Markets ETF
VWO
$124B
| $7.26M | ﹤0.01% |
180,334
-53,681
| -23% | -$2.22M |
|
1038
Watsco Inc
WSO
$13.6B
| $7.25M | ﹤0.01% |
42,857
-394
| -0.9% | -$63.9K |
|
1039
Curtiss-Wright
CW
$25.5B
| $7.24M | ﹤0.01% |
55,947
-2,509
| -4% | -$316K |
|
1040
Oshkosh
OSK
$9.59B
| $7.23M | ﹤0.01% |
95,386
+994
| +1% | +$76.1K |
|
1041
Matador Resources
MTDR
$6.09B
| $7.2M | ﹤0.01% |
435,617
-24,180
| -5% | -$404K |
|
|
IFLN
1042
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$307M
| $7.15M | ﹤0.01% |
375,893
+530
| +0.1% | +$10.1K |
|
|
BERY
1043
DELISTED
Berry Global Group, Inc.
BERY
| $7.05M | ﹤0.01% |
195,392
+2,031
| +1% | +$83K |
|
1044
Spire
SR
$4.85B
| $7.01M | ﹤0.01% |
80,398
+5,993
| +8% | +$505K |
|
1045
Flowers Foods
FLO
$1.57B
| $7.01M | ﹤0.01% |
302,940
+6,146
| +2% | +$142K |
|
1046
Cinemark Holdings
CNK
$4.32B
| $7M | ﹤0.01% |
181,102
-1,619
| -0.9% | -$61.9K |
|
|
ROIC
1047
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $6.97M | ﹤0.01% |
382,461
+54,707
| +17% | +$980K |
|
|
PRAH
1048
DELISTED
PRA Health Sciences, Inc.
PRAH
| $6.97M | ﹤0.01% |
70,233
+6,958
| +11% | +$691K |
|
|
AGR
1049
DELISTED
Avangrid, Inc.
AGR
| $6.93M | ﹤0.01% |
132,578
+1,604
| +1% | +$80.6K |
|
1050
iShares MSCI Canada ETF
EWC
$6.33B
| $6.92M | ﹤0.01% |
239,358
-267,469
| -53% | -$7.62M |
|
Similar funds
UBS AM's Q3 2019 Portfolio in Review
As of Q3 2019, UBS AM held 2,935 positions worth $148B, up 5.8% from $140B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM deployed $6.46B of net new capital in Q3 2019, opening 79 new positions and adding to 1,853 existing holdings. Its largest new stake was 10x Genomics: 184,683 shares worth $9.31M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $167M trimmed.
- UBS AM's largest Q3 2019 buy was 10x Genomics: 184,683 shares worth $9.31M.
- UBS AM added most to Alibaba in Q3 2019, an estimated $495M increase.
- UBS AM's biggest Q3 2019 reduction was Apple, cutting an estimated $167M.
- UBS AM fully exited Total System Services, Inc. in Q3 2019, selling an estimated $225M.
- UBS AM's ten largest holdings make up 19% of its $148B portfolio in Q3 2019.
- UBS AM opened 79 new positions and closed 50 in Q3 2019.
- UBS AM's portfolio value rose 5.8% quarter-over-quarter to $148B.
Based on UBS AM's 13F filing for Q3 2019, filed 14 Nov 2019.